Make Money

Novo says Wegovy injection lowers BMI and obesity rates in children in trial

By CNBC | 1 min read

Novo says Wegovy injection lowers BMI and obesity rates in children in trial

Wegovy is already approved to treat obesity in children ages 12 and older, but there are currently no approved medications for those under 12.

# Novo says Wegovy injection lowers BMI and obesity rates in children in trial Wegovy is already approved to treat obesity in children ages 12 and older, but there are currently no approved medications for those under 12. **Read the full article:** [CNBC](https://www.cnbc.com/2026/11/16/novo-wegovy-obesity-children-trial.html) *This article was originally published by CNBC. MoneyWiseInc provides expert curation of the best financial content from trusted sources.*